Form 4: Director Juan Jose Chacon Quiros Sells ESTA Shares

Director Juan Jose Chacon Quiros sold 75,000 shares of Establishment Labs Holdings Inc. via a Rule 10b5-1 trading plan.

Summary

• Director Juan Jose Chacon Quiros sold a total of 75,000 common shares of Establishment Labs Holdings Inc. (ESTA) between May 1, 2026, and May 4, 2026.
• The sales were executed through a pre-arranged Rule 10b5-1 trading plan.
• The shares were held indirectly by Sariel Group Ltd., an entity over which the director maintains voting and dispositive power.
• The weighted average sale prices ranged from approximately $70.47 to $71.34 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were executed through a pre-planned 10b5-1 program, which is standard practice for corporate insiders.

Positives

• The sales were conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell shares without triggering concerns regarding non-public information.

Negatives

• The transaction represents a significant divestment of 75,000 shares by a company director.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in the short-term growth prospects of the company.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance practice in the medical device sector, often used for liquidity or portfolio diversification rather than signaling fundamental business shifts.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives and directors to manage equity holdings while maintaining compliance with SEC regulations.

Related Party Transactions

• The shares sold were held by Sariel Group Ltd., an entity associated with the reporting person.

Stakeholder Impact

• Shareholders may monitor the reduction in insider holdings, though the use of a 10b5-1 plan mitigates concerns regarding potential insider trading.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Establishment Labs, ESTA, Insider Trading, Form 4, Juan Jose Chacon Quiros, Equity Sale